The forecasted hospital discharges for malignant neoplasm of the ovary in Italy between 2024 and 2028 show a slight decline, with values diminishing from 7.27 thousand in 2024 to 7.25 thousand in 2028. When considering year-on-year variation from 2024 onwards, the changes are minor, with a decrease of roughly 0.14% annually. The compound annual growth rate (CAGR) over five years further supports this subtly decreasing trend.
Looking forward, it will be crucial to monitor several factors, such as advancements in medical treatment, changes in public health policy, and the aging population in Italy, which may influence hospital discharge rates in the future.
